SE0301569D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0301569D0 SE0301569D0 SE0301569A SE0301569A SE0301569D0 SE 0301569 D0 SE0301569 D0 SE 0301569D0 SE 0301569 A SE0301569 A SE 0301569A SE 0301569 A SE0301569 A SE 0301569A SE 0301569 D0 SE0301569 D0 SE 0301569D0
- Authority
- SE
- Sweden
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Priority Applications (66)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0301569A SE0301569D0 (sv) | 2003-05-27 | 2003-05-27 | Novel compounds |
SE0302305A SE0302305D0 (sv) | 2003-05-27 | 2003-08-27 | Novel Compounds |
TW099109193A TW201024261A (en) | 2003-05-27 | 2004-05-19 | Substituted indoles and preparation and use thereof |
TW093114113A TWI328004B (en) | 2003-05-27 | 2004-05-19 | Substituted indoles and use thereof |
ARP040101792A AR044552A1 (es) | 2003-05-27 | 2004-05-24 | Derivados del indol,composiciones farmaceuticas que los contienen y procesos para su preparacion, de utilidad para el tratamiento de trastornos respiratorios |
DK04734774T DK1656346T3 (da) | 2003-05-27 | 2004-05-25 | 1,2,3,4-tetrasubstituerede indol til behandling af luftvejssygdomme |
AT08165755T ATE502010T1 (de) | 2003-05-27 | 2004-05-25 | Verwendung von 3-phenylthio-1h-indol-1-essigsäure-derivate als modulatoren der crth2-rezeptor- aktivität |
EP04734774A EP1656346B1 (en) | 2003-05-27 | 2004-05-25 | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases |
JP2006532212A JP4541361B2 (ja) | 2003-05-27 | 2004-05-25 | 新規3位硫黄置換インドール |
DE602004020072T DE602004020072D1 (de) | 2003-05-27 | 2004-05-25 | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen |
KR1020117009790A KR20110050754A (ko) | 2003-05-27 | 2004-05-25 | 신규한 치환된 3-황 인돌 |
SI200431874T SI2281815T1 (sl) | 2003-05-27 | 2004-05-25 | Vmesna spojina etil estra 4-(acetilamino)-3-((4-klorofenil)tio)-2-metil-1H-indol-1-ocetne kisline |
DE602004031894T DE602004031894D1 (de) | 2003-05-27 | 2004-05-25 | Verwendung von 3-Phenylthio-1H-indol-1-essigsäure-Derivate als Modulatoren der CRTh2-Rezeptor-Aktivität |
CN2004800146027A CN1795174B (zh) | 2003-05-27 | 2004-05-25 | 取代的3-硫吲哚 |
SI200431120T SI1656346T1 (sl) | 2003-05-27 | 2004-05-25 | 1,2,3,4-tetrasubstituiran indol za zdravljenje respiratornih bolezni |
AT10180348T ATE552243T1 (de) | 2003-05-27 | 2004-05-25 | 4-(acetylamino)-3-ä(4-chlorophenyl)thioü-2-meth l-1h-indole-1-essigsäure-ethyl-ester zwischenverbindung |
EP10180348A EP2281815B1 (en) | 2003-05-27 | 2004-05-25 | 4-(Acetylamino)-3-[(4-chlorophenyl)thio]-2-methyl-1H-indole-1-acetic acid ethyl ester intermediate compound |
AT04734774T ATE425965T1 (de) | 2003-05-27 | 2004-05-25 | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen |
PT08165755T PT2025670E (pt) | 2003-05-27 | 2004-05-25 | Utiliza??o de derivados do ?cido 3-feniltio-1h-indole-1-ac?tico como moduladores da actividade dos receptores crth2 |
DK08165755.3T DK2025670T3 (da) | 2003-05-27 | 2004-05-25 | Anvendelse af 3-phenylthio-1H-indol-1-eddikesyre-derivater som modulatorer af CRTh2-receptor aktivitet |
BRPI0410711A BRPI0410711B8 (pt) | 2003-05-27 | 2004-05-25 | ácido 4-(acetilamina)-3-[(4-clorofenil)tio]-2-metil-1h-indol-1-acético |
AU2004242624A AU2004242624B2 (en) | 2003-05-27 | 2004-05-25 | Novel substituted 3-sulfur indoles |
ES10180348T ES2382606T3 (es) | 2003-05-27 | 2004-05-25 | Compuesto intermedio éster etílico del ácido 4-(acetilamino)-3-[(4-clorofenil)tio]-2-metil-1H-indol-acético |
PL08165755T PL2025670T3 (pl) | 2003-05-27 | 2004-05-25 | Zastosowanie pochodnych kwasu 3-fenylotio-1H-indolo-1-octowego jako modulatorów aktywności receptora CRTh2 |
EP08165755A EP2025670B1 (en) | 2003-05-27 | 2004-05-25 | Use of 3-phenylthio-1H-indole-1-acetic acid derivatives as modulators of CRTh2 receptor activity |
PCT/SE2004/000808 WO2004106302A1 (en) | 2003-05-27 | 2004-05-25 | Novel substituted 3-sulfur indoles |
KR1020057022513A KR101067586B1 (ko) | 2003-05-27 | 2004-05-25 | 신규한 치환된 3-황 인돌 |
SI200431669T SI2025670T1 (sl) | 2003-05-27 | 2004-05-25 | Uporaba derivatov 3-feniltio-1H-indol-1-ocetne kisline kot modulatorjev aktivnosti CRTh2 receptorja |
CN2011102633202A CN102391171A (zh) | 2003-05-27 | 2004-05-25 | 新型取代的3-硫吲哚 |
PT04734774T PT1656346E (pt) | 2003-05-27 | 2004-05-25 | Indole 1,2,3,4-tetrassubstituído para o tratamento de doenças respiratórias |
ES04734774T ES2322650T3 (es) | 2003-05-27 | 2004-05-25 | Indol 1,2,3,4-tetrasustituido para el tratamiento de enfermedades respiratorias. |
US10/558,228 US7687535B2 (en) | 2003-05-27 | 2004-05-25 | Substituted 3-sulfur indoles |
RU2005137403/04A RU2361860C2 (ru) | 2003-05-27 | 2004-05-25 | Новые замещенные 3-сера-индолы |
PT10180348T PT2281815E (pt) | 2003-05-27 | 2004-05-25 | Composto intermediário de éster etílico do ácido 4-(acetilamino)-3-[(4-clorofenil)tio]-2-metil-1h-indole- 1-acético |
MYPI20041992A MY144483A (en) | 2003-05-27 | 2004-05-25 | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases |
PL10180348T PL2281815T3 (pl) | 2003-05-27 | 2004-05-25 | Związek pośredni, ester etylowy kwasu 4-(acetyloamino)-3-[(4-chlorofenylo}tio]-2-metylo-1H-indolooctowego |
ES08165755T ES2361485T3 (es) | 2003-05-27 | 2004-05-25 | Uso de derivados de ácido 3-feniltio-1h-indol-acético como moduladores de la actividad del receptor crth2. |
DK10180348.4T DK2281815T3 (da) | 2003-05-27 | 2004-05-25 | 4-(Acetylamino)-3-[(4-chlorophenyl)thio]-2-methyl-1H-indole-1-acetic acid ethyl ester intermediate compound |
MXPA05012680A MXPA05012680A (es) | 2003-05-27 | 2004-05-25 | Indoles novedosos de 3-azufre sustituidos. |
UAA200511010A UA84701C2 (ru) | 2003-05-27 | 2004-05-25 | Замещенные индолы, способ их получения, их использования |
CA2526866A CA2526866C (en) | 2003-05-27 | 2004-05-25 | Substituted 3-sulfur indoles for treating a disease mediated by crth2 |
PL04734774T PL1656346T3 (pl) | 2003-05-27 | 2004-05-25 | 1,2,3,4-Tetrapodstawiony indol do leczenia chorób dróg oddechowych |
NZ543722A NZ543722A (en) | 2003-05-27 | 2004-05-25 | Novel substituted 3-sulfur indoles |
KR1020117009788A KR101067535B1 (ko) | 2003-05-27 | 2004-05-25 | 신규한 치환된 3-황 인돌 |
IL171928A IL171928A (en) | 2003-05-27 | 2005-11-14 | Compounds of 4 - (acetylamino) - 3 - [(4 - chlorophenyl) thio] - 2 - methyl - 1H - indole - 1 - acetic acid, salts and their solvates, and their uses in the preparation of medicine |
CO05118882A CO5630030A2 (es) | 2003-05-27 | 2005-11-23 | Acido 4-(acetilamino)-3-{(4-clorofenil)tio}-2-metil-1h-indol-1-acetico y composicion farmaceutica que lo contiene |
ZA200509598A ZA200509598B (en) | 2003-05-27 | 2005-11-28 | Novel substituted 3-sulfur indoles |
IS8189A IS2722B (is) | 2003-05-27 | 2005-12-20 | 1, 2, 3, 4- Tetrasetin indól til meðhöndlunar á öndunarfærasjúkdómum |
NO20056130A NO20056130L (no) | 2003-05-27 | 2005-12-22 | Nye substituerte 3-svovelindoler |
HK06111158.9A HK1090635A1 (en) | 2003-05-27 | 2006-10-11 | Substituted 3-sulfur indoles |
IL194872A IL194872A0 (en) | 2003-05-27 | 2008-10-23 | Novel substituted 3-sulfur indoles |
US12/397,618 US20090163518A1 (en) | 2003-05-27 | 2009-03-04 | Novel Compounds |
HR20090281T HRP20090281T1 (en) | 2003-05-27 | 2009-05-15 | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases |
CY20091100564T CY1109104T1 (el) | 2003-05-27 | 2009-05-28 | 1,2,3,4 τετρα-υποκατεστημενη ινδολη για την αντιμετωπιση ασθενειων του αναπνευστικου |
HK11107570.0A HK1149563A1 (sv) | 2003-05-27 | 2009-06-30 | |
HK09105852.7A HK1126773A1 (sv) | 2003-05-27 | 2009-06-30 | |
JP2010082748A JP2010155862A (ja) | 2003-05-27 | 2010-03-31 | 新規3位硫黄置換インドール |
IS8920A IS8920A (is) | 2003-05-27 | 2010-08-09 | 3-(Fenýl eða kínólyl)þíó- 1H-idnól-1-ediksýru afleður sem mótarar á virkni CRTh2 vitaka. |
US13/047,280 US20110263614A1 (en) | 2003-05-27 | 2011-03-14 | Novel compounds |
IL212265A IL212265A0 (en) | 2003-05-27 | 2011-04-11 | Novel compounds |
IL212371A IL212371A0 (en) | 2003-05-27 | 2011-04-14 | Novel compounds |
HR20110359T HRP20110359T1 (hr) | 2003-05-27 | 2011-05-16 | Upotreba derivata 3-feniltio-1h-indol-1-octene kiseline kao modulatora crth2 receptorske aktivnosti |
CY20111100464T CY1111469T1 (el) | 2003-05-27 | 2011-05-16 | ΧΡΗΣΗ ΠΑΡΑΓΩΓΩΝ 3-ΦΑΙΝΥΛΘΕΙΟ-1Η-ΙΝΔΟΛΗ-1-ΟΞΙΚΟΥ ΟΞΕΟΣ ΩΣ ΡΥΘΜΙΣΤΕΣ ΤΗΣ ΔΡΑΣΗΣ ΤΟΥ ΥΠΟΔΟΧΕΑ CRTh2 |
US13/344,051 US20120178764A1 (en) | 2003-05-27 | 2012-01-05 | Novel Compounds |
HRP20120390TT HRP20120390T1 (hr) | 2003-05-27 | 2012-05-10 | Intermedijarni spoj etil estera 4-(acetilamino)-3-[(4-klorofenil)tio]-2-metil-1h-indol-1-octene kiseline |
CY20121100486T CY1112853T1 (el) | 2003-05-27 | 2012-05-29 | Ενδιαμεση ενωση 4-(ακετυλαμινο)-3-[(4-χλωροφαινυλ)θειο]-2-μεθυλ-1η-ινδολη-1-οξικο οξυ αιθυλεστερα |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0301569A SE0301569D0 (sv) | 2003-05-27 | 2003-05-27 | Novel compounds |
SE0302305A SE0302305D0 (sv) | 2003-05-27 | 2003-08-27 | Novel Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0301569D0 true SE0301569D0 (sv) | 2003-05-27 |
Family
ID=33492578
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0301569A SE0301569D0 (sv) | 2003-05-27 | 2003-05-27 | Novel compounds |
SE0302305A SE0302305D0 (sv) | 2003-05-27 | 2003-08-27 | Novel Compounds |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0302305A SE0302305D0 (sv) | 2003-05-27 | 2003-08-27 | Novel Compounds |
Country Status (31)
Country | Link |
---|---|
US (4) | US7687535B2 (sv) |
EP (3) | EP1656346B1 (sv) |
JP (2) | JP4541361B2 (sv) |
KR (3) | KR101067535B1 (sv) |
CN (2) | CN102391171A (sv) |
AR (1) | AR044552A1 (sv) |
AT (3) | ATE502010T1 (sv) |
AU (1) | AU2004242624B2 (sv) |
BR (1) | BRPI0410711B8 (sv) |
CA (1) | CA2526866C (sv) |
CO (1) | CO5630030A2 (sv) |
CY (3) | CY1109104T1 (sv) |
DE (2) | DE602004020072D1 (sv) |
DK (3) | DK2025670T3 (sv) |
ES (3) | ES2382606T3 (sv) |
HK (3) | HK1090635A1 (sv) |
HR (3) | HRP20090281T1 (sv) |
IL (4) | IL171928A (sv) |
IS (2) | IS2722B (sv) |
MX (1) | MXPA05012680A (sv) |
MY (1) | MY144483A (sv) |
NO (1) | NO20056130L (sv) |
NZ (1) | NZ543722A (sv) |
PL (3) | PL2025670T3 (sv) |
PT (3) | PT1656346E (sv) |
RU (1) | RU2361860C2 (sv) |
SE (2) | SE0301569D0 (sv) |
SI (3) | SI1656346T1 (sv) |
TW (2) | TW201024261A (sv) |
WO (1) | WO2004106302A1 (sv) |
ZA (1) | ZA200509598B (sv) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0201635D0 (sv) | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
TW200307542A (en) * | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
SE0202241D0 (sv) * | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
SE0301569D0 (sv) * | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
SE0302232D0 (sv) * | 2003-08-18 | 2003-08-18 | Astrazeneca Ab | Novel Compounds |
SE0303180D0 (sv) * | 2003-11-26 | 2003-11-26 | Astrazeneca Ab | Novel compounds |
EP1725553B1 (en) | 2004-03-11 | 2008-05-07 | Actelion Pharmaceuticals Ltd. | Tetrahydropyridoindole derivatives |
CN101084190B (zh) | 2004-12-27 | 2011-01-26 | 埃科特莱茵药品有限公司 | 作为crth2受体拮抗剂的2,3,4,9-四氢-1h-咔唑衍生物 |
GB0500604D0 (en) * | 2005-01-13 | 2005-02-16 | Astrazeneca Ab | Novel process |
DOP2006000016A (es) * | 2005-01-26 | 2006-07-31 | Aventis Pharma Inc | 2-fenil-indoles como antagonistas del receptor de la prostaglandina d2. |
CA2601979C (en) | 2005-04-21 | 2014-06-17 | Laboratoires Serono S.A. | 2,3 substituted pyrazine sulfonamides |
AU2006251138C1 (en) | 2005-05-24 | 2013-08-29 | Merck Serono Sa | Tricyclic spiro derivatives as CRTH2 modulators |
US7956082B2 (en) | 2005-07-22 | 2011-06-07 | Shionogi & Co., Ltd | Indole derivative having PGD2 receptor antagonist activity |
JP5064219B2 (ja) | 2005-07-22 | 2012-10-31 | 塩野義製薬株式会社 | Pgd2受容体アンタゴニスト活性を有するアザインドール酸誘導体 |
RU2405770C2 (ru) | 2005-09-27 | 2010-12-10 | Сионоги Энд Ко., Лтд. | Производное сульфонамида, обладающее антагонистической активностью в отношении рецептора pgd2 |
WO2007036743A2 (en) * | 2005-09-30 | 2007-04-05 | Argenta Discovery Limited | Quinolines and their therapeutic use |
CN102558021A (zh) * | 2006-05-26 | 2012-07-11 | 阿斯利康(瑞典)有限公司 | 联芳基或芳基-杂芳基取代的吲哚类化合物 |
PT2037967T (pt) | 2006-06-16 | 2017-03-14 | Univ Pennsylvania | Antagonistas do recetor de prostaglandina d2 para o tratamento da alopecia androgenética |
US7999119B2 (en) * | 2006-07-22 | 2011-08-16 | Oxagen Limited | Compounds having CRTH2 antagonist activity |
WO2008017989A1 (en) | 2006-08-07 | 2008-02-14 | Actelion Pharmaceuticals Ltd | (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives |
GB0702456D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | New combination |
BRPI0813436A2 (pt) * | 2007-06-21 | 2014-12-23 | Actimis Pharmaceuticals Inc | Particulados de ácido (4,6-bis (dimetilamino)-2-(4-(4-(trifluorometil) benzamido)-benzil)pirimindin-5-il} acético, composição farmacêutica, métodos para o tratamento, prevenção ou melhora de um ou mais sintomas de uma doença mediada por crth2, de uma doença relacionada com eosinófilo, de uma doença relacionada com basófilo, e de uma doença inflamatória, e, processo para a preparação dos particulados. |
UA101326C2 (en) * | 2007-06-21 | 2013-03-25 | Актимис Фармасьютикалз, Инк. | Amine salts of crth2 antagonist |
PT2229358E (pt) | 2007-12-14 | 2011-06-29 | Pulmagen Therapeutics Asthma Ltd | Indoles e sua utilização terapêutica |
US7750027B2 (en) * | 2008-01-18 | 2010-07-06 | Oxagen Limited | Compounds having CRTH2 antagonist activity |
US20110312945A1 (en) * | 2008-10-01 | 2011-12-22 | James Jia | Crth2 modulators |
JP2012517454A (ja) | 2009-02-12 | 2012-08-02 | メルク セローノ ソシエテ アノニム | フェノキシ酢酸誘導体 |
ES2426679T3 (es) | 2009-07-06 | 2013-10-24 | Astrazeneca Ab | Intermedios y procesos para preparar el ácido 4-(acetilamino)-3-[(4-clorofenil)tio]-2-metil-1H-indol-1-acético |
GB0913345D0 (en) | 2009-07-31 | 2009-09-16 | Astrazeneca Ab | New combination 802 |
WO2011061527A1 (en) | 2009-11-17 | 2011-05-26 | Astrazeneca Ab | Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases |
US9032565B2 (en) | 2009-12-16 | 2015-05-19 | Kohler Co. | Touchless faucet assembly and method of operation |
WO2011073662A1 (en) | 2009-12-17 | 2011-06-23 | Astrazeneca Ab | Combination of a benzoxazinone and a further agent for treating respiratory diseases |
AU2011231208B2 (en) | 2010-03-22 | 2015-03-26 | Idorsia Pharmaceuticals Ltd | 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulators |
GB201021992D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | Compound |
GB201021979D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | New compound |
US9096595B2 (en) | 2011-04-14 | 2015-08-04 | Actelion Pharmaceuticals Ltd | 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin D2 receptor modulators |
SG11201402796SA (en) | 2011-12-16 | 2014-06-27 | Atopix Therapeutics Ltd | Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis |
KR102205774B1 (ko) | 2012-03-21 | 2021-01-20 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 모발 성장을 조절하는 방법 및 조성물 |
US9550750B2 (en) * | 2012-10-05 | 2017-01-24 | Merck Sharp & Dohme Corp. | Indoline compounds as aldosterone synthase inhibitors |
US20140303121A1 (en) | 2013-03-15 | 2014-10-09 | Plexxikon Inc. | Heterocyclic compounds and uses thereof |
WO2014145051A1 (en) | 2013-03-15 | 2014-09-18 | Jiazhong Zhang | Heterocyclic compounds and uses thereof |
US20160194299A1 (en) * | 2013-05-24 | 2016-07-07 | The California Institute For Biomedical Research | Compounds for treatment of drug resistant and persistent tuberculosis |
AR099767A1 (es) | 2014-03-17 | 2016-08-17 | Actelion Pharmaceuticals Ltd | Derivados del ácido acético azaindol y su uso como moduladores del receptor de prostaglandina d2 |
CN106103437A (zh) | 2014-03-18 | 2016-11-09 | 埃科特莱茵药品有限公司 | 氮杂吲哚乙酸衍生物及其作为前列腺素d2受体调节剂的用途 |
GB201407807D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
GB201407820D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
CN108472510A (zh) | 2015-07-30 | 2018-08-31 | 宾夕法尼亚大学理事会 | 用于检测pgd2对毛发生长抑制的易感性的人dp-2基因的单核苷酸多态性等位基因 |
ES2867757T3 (es) | 2015-09-15 | 2021-10-20 | Idorsia Pharmaceuticals Ltd | Formas cristalinas |
WO2019075243A1 (en) | 2017-10-13 | 2019-04-18 | Plexxikon Inc. | SOLID FORMS OF A COMPOUND FOR MODULATING KINASES |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE790679A (fr) | 1971-11-03 | 1973-04-27 | Ici Ltd | Derives de l'indole |
JPH0615542B2 (ja) | 1986-07-22 | 1994-03-02 | 吉富製薬株式会社 | ピラゾロピリジン化合物 |
US5095031A (en) * | 1990-08-20 | 1992-03-10 | Abbott Laboratories | Indole derivatives which inhibit leukotriene biosynthesis |
WO1993005020A1 (en) | 1991-09-06 | 1993-03-18 | Merck & Co., Inc. | Indoles as inhibitors of hiv reverse transcriptase |
FR2692574B1 (fr) | 1992-06-23 | 1995-06-23 | Sanofi Elf | Derives hydroxy-4 benzenethio, leur preparation ainsi que leur utilisation pour la preparation de derives aminoalkoxybenzenesulfonyles. |
EP0686148A4 (en) | 1993-02-24 | 1996-02-07 | Merck & Co Inc | INVERSE HIV REVERSE TRANSCRIPTASE INHIBITORS |
US5486525A (en) * | 1993-12-16 | 1996-01-23 | Abbott Laboratories | Platelet activating factor antagonists: imidazopyridine indoles |
US5567711A (en) * | 1995-04-19 | 1996-10-22 | Abbott Laboratories | Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists |
GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
EP0880508B1 (en) | 1996-02-13 | 2003-04-16 | AstraZeneca AB | Quinazoline derivatives as vegf inhibitors |
WO1997032856A1 (en) | 1996-03-05 | 1997-09-12 | Zeneca Limited | 4-anilinoquinazoline derivatives |
TW472045B (en) | 1996-09-25 | 2002-01-11 | Astra Ab | Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
AR017256A1 (es) | 1997-08-21 | 2001-09-05 | American Home Prod | Compuestos de indol sustituidos, metodo para la sintesis en fase solida de los mismos, conjuntos de combinacion para ser empleados en dicho metodo, uso delos compuestos para preparar un medicamento y composiciones farmaceuticas que los comprenden |
DK0924209T3 (da) | 1997-12-19 | 2003-08-25 | Lilly Co Eli | Hypoglykæmiske imidazolinforbindelser |
US6916841B2 (en) * | 1998-02-25 | 2005-07-12 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
AU5886500A (en) | 1999-06-23 | 2001-01-09 | Sepracor, Inc. | Indolyl-benzimidazole antibacterials, and methods of use thereof |
AU7962200A (en) | 1999-10-29 | 2001-05-14 | Wakunaga Pharmaceutical Co., Ltd | Novel indole derivatives and drugs containing the same as the active ingredient |
CA2395593C (en) | 1999-12-24 | 2011-08-02 | Aventis Pharma Limited | Azaindoles |
NZ522074A (en) | 2000-05-31 | 2004-06-25 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
IL153484A0 (en) | 2000-07-07 | 2003-07-06 | Angiogene Pharm Ltd | Colchinol derivatives as angiogenesis inhibitors |
IL153325A0 (en) | 2000-07-07 | 2003-07-06 | Angiogene Pharm Ltd | Colchinol derivatives as angiogenesis inhibitors |
US6878522B2 (en) * | 2000-07-07 | 2005-04-12 | Baiyong Li | Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
JP4595182B2 (ja) * | 2000-09-07 | 2010-12-08 | ソニー株式会社 | 情報記録装置、情報再生装置、情報記録方法、情報再生方法、および情報記録媒体、並びにプログラム提供媒体 |
US6933316B2 (en) * | 2001-12-13 | 2005-08-23 | National Health Research Institutes | Indole compounds |
KR100656037B1 (ko) | 2002-02-01 | 2006-12-11 | 에프. 호프만-라 로슈 아게 | 알파-1 작용제인 치환된 인돌 |
SE0200356D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
SE0200411D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
JP4484108B2 (ja) | 2002-05-16 | 2010-06-16 | 塩野義製薬株式会社 | Pgd2受容体拮抗作用を有する化合物 |
SE0201635D0 (sv) * | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
TW200307542A (en) * | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
SE0202241D0 (sv) * | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
SE0202463D0 (sv) | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | Novel compounds |
SE0301569D0 (sv) | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
SE0302232D0 (sv) | 2003-08-18 | 2003-08-18 | Astrazeneca Ab | Novel Compounds |
AU2004283139A1 (en) | 2003-10-14 | 2005-05-06 | Oxagen Limited | Compounds having CRTH2 antagonist activity |
SE0303180D0 (sv) | 2003-11-26 | 2003-11-26 | Astrazeneca Ab | Novel compounds |
GB0500604D0 (en) * | 2005-01-13 | 2005-02-16 | Astrazeneca Ab | Novel process |
GB2422831A (en) | 2005-02-04 | 2006-08-09 | Oxagen Ltd | Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor |
CN102558021A (zh) * | 2006-05-26 | 2012-07-11 | 阿斯利康(瑞典)有限公司 | 联芳基或芳基-杂芳基取代的吲哚类化合物 |
AU2007256564A1 (en) | 2006-06-08 | 2007-12-13 | Neurokey A/S | Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia |
KR20090023645A (ko) | 2006-06-28 | 2009-03-05 | 사노피-아벤티스 | 신규한 cxcr2 억제제 |
-
2003
- 2003-05-27 SE SE0301569A patent/SE0301569D0/sv unknown
- 2003-08-27 SE SE0302305A patent/SE0302305D0/sv unknown
-
2004
- 2004-05-19 TW TW099109193A patent/TW201024261A/zh unknown
- 2004-05-19 TW TW093114113A patent/TWI328004B/zh not_active IP Right Cessation
- 2004-05-24 AR ARP040101792A patent/AR044552A1/es unknown
- 2004-05-25 KR KR1020117009788A patent/KR101067535B1/ko not_active IP Right Cessation
- 2004-05-25 RU RU2005137403/04A patent/RU2361860C2/ru active
- 2004-05-25 CN CN2011102633202A patent/CN102391171A/zh active Pending
- 2004-05-25 BR BRPI0410711A patent/BRPI0410711B8/pt not_active IP Right Cessation
- 2004-05-25 CN CN2004800146027A patent/CN1795174B/zh not_active Expired - Fee Related
- 2004-05-25 SI SI200431120T patent/SI1656346T1/sl unknown
- 2004-05-25 DK DK08165755.3T patent/DK2025670T3/da active
- 2004-05-25 SI SI200431669T patent/SI2025670T1/sl unknown
- 2004-05-25 WO PCT/SE2004/000808 patent/WO2004106302A1/en active Application Filing
- 2004-05-25 CA CA2526866A patent/CA2526866C/en not_active Expired - Fee Related
- 2004-05-25 KR KR1020057022513A patent/KR101067586B1/ko active IP Right Grant
- 2004-05-25 DE DE602004020072T patent/DE602004020072D1/de active Active
- 2004-05-25 EP EP04734774A patent/EP1656346B1/en active Active
- 2004-05-25 EP EP08165755A patent/EP2025670B1/en active Active
- 2004-05-25 PT PT04734774T patent/PT1656346E/pt unknown
- 2004-05-25 DE DE602004031894T patent/DE602004031894D1/de active Active
- 2004-05-25 PL PL08165755T patent/PL2025670T3/pl unknown
- 2004-05-25 SI SI200431874T patent/SI2281815T1/sl unknown
- 2004-05-25 PT PT08165755T patent/PT2025670E/pt unknown
- 2004-05-25 MY MYPI20041992A patent/MY144483A/en unknown
- 2004-05-25 US US10/558,228 patent/US7687535B2/en active Active
- 2004-05-25 AU AU2004242624A patent/AU2004242624B2/en not_active Ceased
- 2004-05-25 PT PT10180348T patent/PT2281815E/pt unknown
- 2004-05-25 ES ES10180348T patent/ES2382606T3/es active Active
- 2004-05-25 ES ES04734774T patent/ES2322650T3/es active Active
- 2004-05-25 ES ES08165755T patent/ES2361485T3/es active Active
- 2004-05-25 DK DK10180348.4T patent/DK2281815T3/da active
- 2004-05-25 AT AT08165755T patent/ATE502010T1/de active
- 2004-05-25 DK DK04734774T patent/DK1656346T3/da active
- 2004-05-25 EP EP10180348A patent/EP2281815B1/en active Active
- 2004-05-25 MX MXPA05012680A patent/MXPA05012680A/es active IP Right Grant
- 2004-05-25 PL PL10180348T patent/PL2281815T3/pl unknown
- 2004-05-25 KR KR1020117009790A patent/KR20110050754A/ko not_active Application Discontinuation
- 2004-05-25 AT AT04734774T patent/ATE425965T1/de active
- 2004-05-25 AT AT10180348T patent/ATE552243T1/de active
- 2004-05-25 NZ NZ543722A patent/NZ543722A/xx not_active IP Right Cessation
- 2004-05-25 JP JP2006532212A patent/JP4541361B2/ja not_active Expired - Fee Related
- 2004-05-25 PL PL04734774T patent/PL1656346T3/pl unknown
-
2005
- 2005-11-14 IL IL171928A patent/IL171928A/en not_active IP Right Cessation
- 2005-11-23 CO CO05118882A patent/CO5630030A2/es active IP Right Grant
- 2005-11-28 ZA ZA200509598A patent/ZA200509598B/en unknown
- 2005-12-20 IS IS8189A patent/IS2722B/is unknown
- 2005-12-22 NO NO20056130A patent/NO20056130L/no not_active Application Discontinuation
-
2006
- 2006-10-11 HK HK06111158.9A patent/HK1090635A1/xx not_active IP Right Cessation
-
2008
- 2008-10-23 IL IL194872A patent/IL194872A0/en unknown
-
2009
- 2009-03-04 US US12/397,618 patent/US20090163518A1/en not_active Abandoned
- 2009-05-15 HR HR20090281T patent/HRP20090281T1/xx unknown
- 2009-05-28 CY CY20091100564T patent/CY1109104T1/el unknown
- 2009-06-30 HK HK11107570.0A patent/HK1149563A1/xx not_active IP Right Cessation
- 2009-06-30 HK HK09105852.7A patent/HK1126773A1/xx not_active IP Right Cessation
-
2010
- 2010-03-31 JP JP2010082748A patent/JP2010155862A/ja active Pending
- 2010-08-09 IS IS8920A patent/IS8920A/is unknown
-
2011
- 2011-03-14 US US13/047,280 patent/US20110263614A1/en not_active Abandoned
- 2011-04-11 IL IL212265A patent/IL212265A0/en unknown
- 2011-04-14 IL IL212371A patent/IL212371A0/en unknown
- 2011-05-16 CY CY20111100464T patent/CY1111469T1/el unknown
- 2011-05-16 HR HR20110359T patent/HRP20110359T1/hr unknown
-
2012
- 2012-01-05 US US13/344,051 patent/US20120178764A1/en not_active Abandoned
- 2012-05-10 HR HRP20120390TT patent/HRP20120390T1/hr unknown
- 2012-05-29 CY CY20121100486T patent/CY1112853T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0301569D0 (sv) | Novel compounds | |
DK1605897T3 (da) | Polyethelen-glycol-link-glp-1-forbindelser | |
IS8108A (is) | Ný efnasambönd | |
IS8228A (is) | Ný asetídínefnasambönd | |
ECSP066436A (es) | Compuestos heterociclicos fusionados | |
ATE368042T1 (de) | Cephemverbindungen | |
IS8089A (is) | Efnasambönd | |
IS7381A (is) | Efnasambönd | |
IS8292A (is) | Ný efnasambönd | |
IS7414A (is) | Oxó-azabísýklísk efnasambönd | |
AT502792A5 (de) | Düsenanpressvorrichtung | |
NO20045659L (no) | Forbindelser | |
DK1633719T3 (da) | Substituerede spirobenzazepiner | |
DE502004009935D1 (de) | Substituierte dihydrochinazoline ii | |
NO20031736D0 (no) | Forbindelser | |
SE0303452D0 (sv) | New compounds | |
SE0203348D0 (sv) | Novel compounds | |
SE0300388D0 (sv) | Novel compounds | |
SE0302667D0 (sv) | Novel Compounds | |
SE0300118D0 (sv) | Novel Compounds | |
AT6592U3 (de) | Frontgrubber | |
NO20035294D0 (no) | Forbindelser | |
NO20030117D0 (no) | Forbindelser | |
NO20033173D0 (no) | Forbindelser | |
SE0301246D0 (sv) | New compounds |